Jnana Therapeutics
Andreu Viader is a Senior Director at Jnana Therapeutics. Previously, Andreu worked as a Principal Scientist at Axcella and a Senior Scientist at Abide Therapeutics, where Andreu led a discovery program for a treatment of NASH and drove pharmacology studies in new therapeutic areas. With a Ph.D. in Neurosciences from Washington University in St. Louis and a B.A. in Biochemistry and Neurosciences from Hamilton College, Andreu has a strong research background in metabolic pathways and neuroinflammation. Andreu has also worked as a Life Sciences Analyst at Tech Coast Angels, a Consultant for startup biotechnology companies, and a Graduate Student at Washington University where Andreu developed a mouse model of diabetic neuropathy.
This person is not in any teams
Jnana Therapeutics
1 followers
Jnana is building the first drug discovery platform dedicated to SLC transporters. This proprietary chemistry and biology platform allows the company to rapidly and comprehensively address therapeutic targets across the greater the 400-member membrane protein family